Mankind Pharma's Stock Reaches All-Time High, Outperforms Sensex in Past Year

Mankind Pharma, a leading pharmaceutical company in India, has recently reached an all-time high in its stock price on October 14, 2024. The company, which falls under the largecap category, has been performing well in the market with its stock gaining 3.97% in the last two days.

According to MarketsMOJO, a leading stock market analysis platform, the current recommendation for Mankind Pharma's stock is 'Hold'. The stock has also been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.

On October 14, the stock hit a new 52-week high of Rs. 2839, which is also its all-time high. The stock's performance today has been in line with the overall sector, and it has shown high volatility with an intraday volatility of 114.94%.

In the past year, Mankind Pharma's stock has outperformed the Sensex, with a 54.46% return compared to the Sensex's 23.07% return. This showcases the company's strong performance and growth in the pharmaceutical industry.

Mankind Pharma has been making strides in the pharmaceutical market with its wide range of products and strong distribution network. With its consistent growth and positive market performance, the company continues to be a strong player in the industry.